Evaluation based on Monte Carlo simulation of lifetime attributable risk of cancer after neck X-ray radiography
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Seo, Deoknam | - |
dc.contributor.author | Han, Seonggyu | - |
dc.contributor.author | Kim, Kie Hwan | - |
dc.contributor.author | Kim, Jungsu | - |
dc.contributor.author | Park, Kyung | - |
dc.contributor.author | Lim, Hyunjong | - |
dc.contributor.author | Kim, Jungmin | - |
dc.date.accessioned | 2021-09-04T10:52:08Z | - |
dc.date.available | 2021-09-04T10:52:08Z | - |
dc.date.created | 2021-06-10 | - |
dc.date.issued | 2015-11 | - |
dc.identifier.issn | 0033-8362 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/91970 | - |
dc.description.abstract | At present, concern regarding radiation exposure is increasing with the prevalence of radiologic examination. As radiation damages the human body, we have evaluated medical radiation dose values and studied the importance of optimizing radiation exposure. We measured entrance surface dose (ESD) values using a RANDO(A (R)) phantom (neck) in 94 randomly selected locations in the central region of Korea. Thyroid and organ doses were calculated using Monte Carlo simulations (PCXMC 2.0.1) based on measured values. In addition, the lifetime attributable risk (LAR) of cancer was calculated for the thyroid, using the method proposed in the biological effects of ionizing radiation VII report. The average measured ESD values obtained using the RANDO(A (R)) phantom (neck) were antero-posterior 1.33 mGy and lateral 1.23 mGy, for a total of 2.56 mGy. Based on the ESD values measured using the phantom, the organ doses were obtained using a Monte Carlo simulation (PCXMC 2.0.1). The thyroid dose was 1.48 mSv on average. In evaluating the LAR of thyroid cancer incidence, a frequency of 0.02 per 100,000 from 2.94 per 100,000 males and a frequency of 0.10 per 100,000 from 16.23 per 100,000 females were found. The risk of cancer was found to be higher when the patient's age was lower, and was also higher in females than in males. It was concluded that beneficial exams in the medical field should not be prohibited because of a statistically small risk, although acknowledgement of the dangers of ionizing radiation is necessary. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | SPRINGER-VERLAG ITALIA SRL | - |
dc.subject | REPAIR | - |
dc.title | Evaluation based on Monte Carlo simulation of lifetime attributable risk of cancer after neck X-ray radiography | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Kim, Jungmin | - |
dc.identifier.doi | 10.1007/s11547-015-0543-z | - |
dc.identifier.scopusid | 2-s2.0-84944176615 | - |
dc.identifier.wosid | 000362913300007 | - |
dc.identifier.bibliographicCitation | RADIOLOGIA MEDICA, v.120, no.11, pp.1043 - 1049 | - |
dc.relation.isPartOf | RADIOLOGIA MEDICA | - |
dc.citation.title | RADIOLOGIA MEDICA | - |
dc.citation.volume | 120 | - |
dc.citation.number | 11 | - |
dc.citation.startPage | 1043 | - |
dc.citation.endPage | 1049 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Radiology, Nuclear Medicine & Medical Imaging | - |
dc.relation.journalWebOfScienceCategory | Radiology, Nuclear Medicine & Medical Imaging | - |
dc.subject.keywordPlus | REPAIR | - |
dc.subject.keywordAuthor | Entrance surface dose (ESD) | - |
dc.subject.keywordAuthor | Lifetime attributable risk (LAR) | - |
dc.subject.keywordAuthor | Organ doses | - |
dc.subject.keywordAuthor | Monte Carlo simulation | - |
dc.subject.keywordAuthor | PCXMC | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.